Abstract
AbstractDrug discovery has traditionally been based on a process of molecular roulette in which large numbers of compounds are tested for biological activity in animals. This is slow and expensive, and does not have very good odds for success. Typically, introduction of a new drug costs $100m–200m in research and development, and only about 40 new chemical entities are introduced each year despite an estimated $20 000m annual expenditure on pharmaceutical research worldwide. Increasingly, research on drug discovery involves highly integrated interdisciplinary teams, and the use of modern technology. Three themes can be discerned in drug discovery research: computer aided drug design, development of new therapeutic targets, and exploitation of new sources of lead compounds. Most benefits will result from synergistic interactions between these three themes. Computer based drug design can focus either on postulated targets or on postulated lead compounds. Although gene cloning provides a vast database of seq...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.